Intensive versus guideline-recommended blood pressure reduction in acute lacunar stroke with intravenous thrombolysis therapy: The ENCHANTED trial.
Zien ZhouChao XiaCheryl CarcelSohei YoshimuraXia WangCandice DelcourtAlejandra MalaveraXiaoying ChenGrant MairMark WoodwardJohn ChalmersAndrew M DemchukRichard I LindleyThompson G RobinsonMark W ParsonsJoanna M WardlawCraig S AndersonPublished in: European journal of neurology (2020)
There were no differences in the treatment effect of early intensive versus guideline-recommended BP lowering across lacunar and non-lacunar AIS.
Keyphrases
- blood pressure
- liver failure
- pulmonary embolism
- atrial fibrillation
- clinical trial
- study protocol
- respiratory failure
- high dose
- randomized controlled trial
- phase iii
- phase ii
- drug induced
- acute ischemic stroke
- hypertensive patients
- metabolic syndrome
- skeletal muscle
- open label
- mesenchymal stem cells
- bone marrow
- subarachnoid hemorrhage
- cerebral ischemia